Literature DB >> 23900607

Subretinal gene therapy of mice with Bardet-Biedl syndrome type 1.

Seongjin Seo1, Robert F Mullins, Alina V Dumitrescu, Sajag Bhattarai, Daniel Gratie, Kai Wang, Edwin M Stone, Val Sheffield, Arlene V Drack.   

Abstract

PURPOSE: To study safety and efficacy of subretinal adeno-associated virus (AAV) vector AAV-Bbs1 injection for treatment of a mouse model of Bardet-Biedl syndrome type 1 (BBS1).
METHODS: Constructs containing a wild-type (WT) Bbs1 gene with and without a FLAG tag in AAV2/5 vectors were generated. Viral genomes were delivered by subretinal injection to right eyes and sham injections to left eyes at postnatal day 30 (P30) to P60. Transgene expression and BBSome reconstitution were evaluated by immunohistochemistry and Western blotting following sucrose gradient ultracentrifugation. Retinal function was analyzed by electroretinogram (ERG) and structure by optical coherence tomography (OCT). Histology and immunohistochemistry were performed on selected eyes.
RESULTS: Expression of FLAG-tagged Bbs1 was demonstrated in photoreceptor cells using antibody directed against the FLAG tag. Coinjection of AAV-GFP demonstrated transduction of 24% to 32% of the retina. Western blotting demonstrated BBS1 protein expression and reconstitution of the BBSome. ERG dark-adapted bright flash b-wave amplitudes were higher in AAV-Bbs1-injected eyes than in sham-injected fellow eyes in more than 50% of 19 animals. Anti-rhodopsin staining demonstrated improved localization of rhodopsin in AAV-Bbs1-treated eyes. WT retinas injected with AAV-Bbs1 with or without a FLAG tag showed outer retinal degeneration on ERG, OCT, and histology.
CONCLUSIONS: In a knock-in model of BBS1, subretinal delivery of AAV-Bbs1 rescues BBSome formation and rhodopsin localization, and shows a trend toward improved ERG. BBS is challenging to treat with gene therapy due to the stoichiometry of the BBSome protein complex and overexpression toxicity.

Entities:  

Keywords:  AAV vector; Bardet Biedl syndrome; gene therapy; mouse model; retinal degeneration

Mesh:

Substances:

Year:  2013        PMID: 23900607      PMCID: PMC3771708          DOI: 10.1167/iovs.13-11673

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  31 in total

1.  A core complex of BBS proteins cooperates with the GTPase Rab8 to promote ciliary membrane biogenesis.

Authors:  Maxence V Nachury; Alexander V Loktev; Qihong Zhang; Christopher J Westlake; Johan Peränen; Andreas Merdes; Diane C Slusarski; Richard H Scheller; J Fernando Bazan; Val C Sheffield; Peter K Jackson
Journal:  Cell       Date:  2007-06-15       Impact factor: 41.582

2.  Missense mutation in the USH2A gene: association with recessive retinitis pigmentosa without hearing loss.

Authors:  C Rivolta; E A Sweklo; E L Berson; T P Dryja
Journal:  Am J Hum Genet       Date:  2000-04-20       Impact factor: 11.025

3.  TUDCA slows retinal degeneration in two different mouse models of retinitis pigmentosa and prevents obesity in Bardet-Biedl syndrome type 1 mice.

Authors:  Arlene V Drack; Alina V Dumitrescu; Sajag Bhattarai; Daniel Gratie; Edwin M Stone; Robert Mullins; Val C Sheffield
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-05       Impact factor: 4.799

4.  Application of acrylamide as an embedding medium in studies of lectin and antibody binding in the vertebrate retina.

Authors:  L V Johnson; J C Blanks
Journal:  Curr Eye Res       Date:  1984-07       Impact factor: 2.424

5.  Insect cells as a factory to produce adeno-associated virus type 2 vectors.

Authors:  Masashi Urabe; Chuantian Ding; Robert M Kotin
Journal:  Hum Gene Ther       Date:  2002-11-01       Impact factor: 5.695

6.  Bbs2-null mice have neurosensory deficits, a defect in social dominance, and retinopathy associated with mislocalization of rhodopsin.

Authors:  Darryl Y Nishimura; Melissa Fath; Robert F Mullins; Charles Searby; Michael Andrews; Roger Davis; Jeaneen L Andorf; Kirk Mykytyn; Ruth E Swiderski; Baoli Yang; Rivka Carmi; Edwin M Stone; Val C Sheffield
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-11       Impact factor: 11.205

7.  Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness.

Authors:  Gregory M Acland; Gustavo D Aguirre; Jean Bennett; Tomas S Aleman; Artur V Cideciyan; Jeannette Bennicelli; Nadine S Dejneka; Susan E Pearce-Kelling; Albert M Maguire; Krzysztof Palczewski; William W Hauswirth; Samuel G Jacobson
Journal:  Mol Ther       Date:  2005-10-14       Impact factor: 11.454

8.  Mutations in C8orf37, encoding a ciliary protein, are associated with autosomal-recessive retinal dystrophies with early macular involvement.

Authors:  Alejandro Estrada-Cuzcano; Kornelia Neveling; Susanne Kohl; Eyal Banin; Ygal Rotenstreich; Dror Sharon; Tzipora C Falik-Zaccai; Stephanie Hipp; Ronald Roepman; Bernd Wissinger; Stef J F Letteboer; Dorus A Mans; Ellen A W Blokland; Michael P Kwint; Sabine J Gijsen; Ramon A C van Huet; Rob W J Collin; H Scheffer; Joris A Veltman; Eberhart Zrenner; Anneke I den Hollander; B Jeroen Klevering; Frans P M Cremers
Journal:  Am J Hum Genet       Date:  2011-12-15       Impact factor: 11.025

9.  A knockin mouse model of the Bardet-Biedl syndrome 1 M390R mutation has cilia defects, ventriculomegaly, retinopathy, and obesity.

Authors:  Roger E Davis; Ruth E Swiderski; Kamal Rahmouni; Darryl Y Nishimura; Robert F Mullins; Khristofor Agassandian; Alisdair R Philp; Charles C Searby; Michael P Andrews; Stewart Thompson; Christopher J Berry; Daniel R Thedens; Baoli Yang; Robert M Weiss; Martin D Cassell; Edwin M Stone; Val C Sheffield
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-21       Impact factor: 11.205

10.  Transgenic mice with a rhodopsin mutation (Pro23His): a mouse model of autosomal dominant retinitis pigmentosa.

Authors:  J E Olsson; J W Gordon; B S Pawlyk; D Roof; A Hayes; R S Molday; S Mukai; G S Cowley; E L Berson; T P Dryja
Journal:  Neuron       Date:  1992-11       Impact factor: 17.173

View more
  38 in total

Review 1.  Gene therapy using stem cells.

Authors:  Erin R Burnight; Luke A Wiley; Robert F Mullins; Edwin M Stone; Budd A Tucker
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-13       Impact factor: 6.915

2.  Using CRISPR-Cas9 to Generate Gene-Corrected Autologous iPSCs for the Treatment of Inherited Retinal Degeneration.

Authors:  Erin R Burnight; Manav Gupta; Luke A Wiley; Kristin R Anfinson; Audrey Tran; Robinson Triboulet; Jeremy M Hoffmann; Darcey L Klaahsen; Jeaneen L Andorf; Chunhua Jiao; Elliott H Sohn; Malavika K Adur; Jason W Ross; Robert F Mullins; George Q Daley; Thorsten M Schlaeger; Edwin M Stone; Budd A Tucker
Journal:  Mol Ther       Date:  2017-06-12       Impact factor: 11.454

3.  Essential role of the chaperonin CCT in rod outer segment biogenesis.

Authors:  Satyabrata Sinha; Marycharmain Belcastro; Poppy Datta; Seongjin Seo; Maxim Sokolov
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-22       Impact factor: 4.799

4.  Using Patient-Specific Induced Pluripotent Stem Cells and Wild-Type Mice to Develop a Gene Augmentation-Based Strategy to Treat CLN3-Associated Retinal Degeneration.

Authors:  Luke A Wiley; Erin R Burnight; Arlene V Drack; Bailey B Banach; Dalyz Ochoa; Cathryn M Cranston; Robert A Madumba; Jade S East; Robert F Mullins; Edwin M Stone; Budd A Tucker
Journal:  Hum Gene Ther       Date:  2016-07-11       Impact factor: 5.695

Review 5.  Bardet-Biedl Syndrome.

Authors:  Evgeny N Suspitsin; Evgeny N Imyanitov
Journal:  Mol Syndromol       Date:  2016-04-15

Review 6.  Olfactory Loss and Dysfunction in Ciliopathies: Molecular Mechanisms and Potential Therapies.

Authors:  Cedric R Uytingco; Warren W Green; Jeffrey R Martens
Journal:  Curr Med Chem       Date:  2019       Impact factor: 4.530

Review 7.  CLINICAL PROGRESS IN INHERITED RETINAL DEGENERATIONS: GENE THERAPY CLINICAL TRIALS AND ADVANCES IN GENETIC SEQUENCING.

Authors:  Brian P Hafler
Journal:  Retina       Date:  2017-03       Impact factor: 4.256

Review 8.  Use of human pluripotent stem cells to study and treat retinopathies.

Authors:  Karim Ben M'Barek; Florian Regent; Christelle Monville
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

9.  Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research.

Authors:  Mark C Butler; Jack M Sullivan
Journal:  J Vis Exp       Date:  2018-11-02       Impact factor: 1.355

10.  CEP290 gene transfer rescues Leber congenital amaurosis cellular phenotype.

Authors:  E R Burnight; L A Wiley; A V Drack; T A Braun; K R Anfinson; E E Kaalberg; J A Halder; L M Affatigato; R F Mullins; E M Stone; B A Tucker
Journal:  Gene Ther       Date:  2014-05-08       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.